GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annua
Go back to GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annua| (NASDAQ: GRAL) | Delayed: 62.40 +0.30 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.10 | 52 Week High | $ | |||
| Open | $60.00 | 52 Week Low | $ | |||
| Day High | $63.82 | P/E | N/A | |||
| Day Low | $60.00 | EPS | $ | |||
| Volume | 138,639 | |||||
